MyMyelomaTeam

While denosumab is commonly used in myeloma treatment, it's important to be aware that it can increase the risk of developing osteonecrosis of the jaw. Before switching medications, it would be advisable to discuss this with both your oncologist and dentist.

If you're experiencing ongoing bone concerns, your healthcare Show Full Answer

While denosumab is commonly used in myeloma treatment, it's important to be aware that it can increase the risk of developing osteonecrosis of the jaw. Before switching medications, it would be advisable to discuss this with both your oncologist and dentist.

If you're experiencing ongoing bone concerns, your healthcare team may need to reevaluate your overall treatment plan, as bone health is a crucial aspect of myeloma management. It's important to note that treatment plans often need to be tailored to each individual's specific situation. Factors such as age, disease severity, and overall health status all play a role in determining the most effective treatment approach. Your oncologist will be best positioned to evaluate whether a change in medication is appropriate for your specific case.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Medications for Multiple Myeloma: Your Guide

5 Dental Issues Linked to Multiple Myeloma: Risk Factors and Treatment